aod9604 fat loss efficacy clinical trials trial aod9604 clinical fat loss side effects AOD-9604 aod9604 fat loss mechanism efficacy

What is the difference between B12 and cyanocobalamin

In a 26-week rat oral toxicity study, AOD-9604 produced dose-dependent changes in serum osteocalcin (a bone-turnover marker) at week 13, with the direction reversing by week 26

B12 injections support the processes that help make weight loss easierlike increased energy, improved metabolism, and reduced fatigue

There is no human clinical trial establishing any effective or safe human dose, oral or injected

Allergic reactions to cyanocobalamin have been reported and require immediate medical attention

The marginal benefit of adding AOD 9604 to a protocol that is already delivering 20%+ body weight reduction is questionable